Purchase Order 75N91020P01000

<p>The National Cancer Institute awarded a purchase order to Bulldog Bio, Inc. for $17,925.75 on September 17, 2020, for an electro-kinetic transfection system to support prostate cancer organoid research. Place of performance is Portsmouth, New Hampshire. The order carries firm fixed price terms and was completed by October 16, 2020. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Bulldog Bio, Inc. for $17,601.50 on August 6, 2020, with ultimate completion the same date. The order procures an electroporation system to introduce mRNA into oocyte cells for research performed by Takashi Akera. Place of performance is Portsmouth, New Hampshire. Pricing is firm fixed price.</p>

The U.S. Department of Health and Human Services, Pacific West Area, awarded a firm fixed-price purchase order to Bulldog Bio, Inc. for an electroporator device with square wave capability and advanced control features including four-pulse control, four-phase voltage control, and reverse polarity control. The contract, valued at $16,925.75, was awarded on August 22, 2019, with an ultimate completion date of December 9, 2022. No small business set-aside was utilized for this procurement. The...

<p>The National Human Genome Research Institute awarded a purchase order to Bulldog Bio, Inc. for $15,222.20 on December 7, 2017, with final completion due November 30, 2018. No small business set-aside applies. Work is performed in Bethesda, Maryland. The order is for advanced laboratory equipment and scientific research technologies, specifically electroporation and gene editing systems supporting genomic research operations.</p>

This contract award to Bulldog Bio, Inc. is for the purchase of an electro kinetic transfer system by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services. The fixed-price purchase order, valued at $16,995.00, does not have a set-aside designation. Bulldog Bio, a for-profit organization, has received multiple prior federal contract awards from various NIH entities and the U.S. Department of Agriculture to...

<p>The National Cancer Institute awarded a purchase order to Eppendorf North America, Inc. for $12,841.60 on September 22, 2020, with completion on December 22, 2020. The order covers laboratory equipment on a firm fixed-price basis. Place of performance is Bethesda, Maryland.</p>

<p>The National Cancer Institute awarded a purchase order to Biocytogen LLC for $10,000.00 on April 3, 2018. Work is performed in Worcester, Massachusetts. The order carries a firm fixed price for commercial items, with ultimate completion on May 3, 2018. No small business set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $48,544.00 on August 7, 2026, with an ultimate completion date of August 6, 2027. The order is firm fixed price with no set-aside applied. Work is performed in Carlsbad, California. The purchase order procures EVOS M7000 laboratory imaging equipment.</p>

<p>The National Cancer Institute awarded a purchase order to Applied Biophysics, Inc. for $16,524.50 in scientific equipment on July 10, 2019, with completion scheduled for July 29, 2019. Performance occurs in Troy, New York. The order covers specialized scientific instrumentation for research laboratory use.</p>

<p>The National Cancer Institute awarded a purchase order to Eppendorf North America, Inc. for an epMotion Performance Plan with premium service, full maintenance, parts, and labor discount on an epMotion 5075 instrument with a ceiling value of $10,900.55, awarded June 25, 2018. The order is a firm fixed-price purchase order with no small business set-aside. Work is performed at Bethesda, Maryland. The performance period runs from July 2, 2018 through July 1, 2019.</p>